Project description:Video 1Two-devices-in-one-channel method with a SpyGlass retrieval basket (Boston Scientific, Marlborough, Mass, USA) grabbing and pulling one of the previously placed through-the-scope clips and biliary cannulation with a conventional sphincterotome, using the double-guidewire technique.

| S-EPMC10927703 | biostudies-literature

Cannulation of an intradiverticular papilla using a novel slim colonoscope with a short-bending section.

Project description:Video 1The magnetic resonance cholangiography showed an abrupt narrowing of the terminal common bile duct.Video 2Biliary drainage at the end of the procedure.

| S-EPMC9716575 | biostudies-literature

Argon plasma coagulation therapy after submucosal injection of normal saline solution for local recurrence of large nonampullary duodenal neoplasm.

Project description: Not available

| S-EPMC5989304 | biostudies-literature

The impact of periampullary diverticula on cannulation and adverse events in endoscopic retrograde cholangiopancreatography.

Project description:BackgroundPeriampullary diverticulum (PAD) is commonly encountered in endoscopic retrograde cholangiopancreatography (ERCP) procedures.ObjectivesWe sought to determine whether PADs are associated with a lower success rate of cannulation and an increased risk of adverse events.DesignA retrospective cohort study was conducted using prospectively gathered nationwide registry data.MethodsUsing the Swedish registry for gallstone surgery and ERCP, we analyzed a cohort of 66,974 prospectively registered ERCP procedures performed in 2006-2021. The presence of PAD was divided into two groups based on the PAD type: Boix type 1 (the papilla located inside the PAD) and Boix types 2-3 (the papilla located either at the edge of the PAD or immediately adjacent to the PAD). The primary outcomes were the success rate of cannulation and overall adverse events within 30 days.ResultsPADs were registered in 8130 (12.1%) of ERCPs included in the study population. In total, 2114 (3.9%) patients had Boix type 1 PAD, while 5035 (8.2%) patients had Boix type 2 or 3 PAD. The chance of successful cannulation was lower in patients with type 1 PAD compared to no PAD (80.1% vs 88.7%; odds ratio: 0.42, 95% confidence interval: 0.38-0.46). No differences were seen in overall adverse events or post-ERCP pancreatitis. Adverse events occurred in 14.6% of patients with PAD type 1 and 16.0% of patients with PAD type 2 or 3, compared to 16.5% of patients without a PAD.ConclusionCannulation appears less successful during ERCP when the papilla is located in the PAD (i.e., type 1). Adverse events seem not to increase with the presence of a PAD, but they could theoretically be influenced by the inability to cannulate.

| S-EPMC11470493 | biostudies-literature

A new pancreatic guidewire-assisted biliary cannulation technique using double soft-tipped guidewire: wire bridge cannulation.

Project description: Not available

| S-EPMC11009448 | biostudies-literature

Saline-immersion endoscopic submucosal dissection using pocket-creation method.

Project description:Video 1Saline-immersion endoscopic submucosal dissection using the pocket-creation method.

| S-EPMC10794121 | biostudies-literature

Comparison of guidewires for successful cannulation of biliary stenosis and targeting of biliary branches in ERCP

Project description:Background and study aims

| S-EPMC10473887 | biostudies-literature

Endoscopic Submucosal Dissection of Papillary Gastric Adenocarcinoma; Systematic Review.

Project description:This study evaluated the possibility of endoscopic submucosal dissection (ESD) for early gastric cancer with papillary adenocarcinoma (EGC-PAC). PAC, an uncommon pathologic type of stomach cancer, is classified into differentiated-type histology. However, aggressive features, including a high rate of submucosal invasion, lymphovascular invasion (LVI), and lymph node metastasis (LNM), have been reported in studies with surgical specimens. Treatment outcomes of ESD for EGC-PAC have not been precisely demonstrated. Core databases were sought for the following inclusion criteria: studies of endoscopic resection or surgery of EGC-PAC presenting the following therapeutic indicators; en bloc resection, complete resection, curative resection, recurrence, complications associated with procedures, LVI, or LNM that enabled an analysis of ESD possibility. Overall, 15 studies were included for systematic review. Frequent submucosal invasion and high LVI were noted in EGC-PAC. However, PAC was not significantly associated with LNM. Pooled en bloc resection, complete resection, and curative resection rates were 89.7% (95% confidence interval: 55.3%-98.4%), 85.3% (67.7%-94.2%), and 67% (43%-84.5%), respectively. No LNM was observed if EGC-PAC satisfied the curative resection criteria. ESD seems technically feasible, although a high LVI rate results in a lower rate of curative resection.

| S-EPMC7290846 | biostudies-literature

Submucosal steroid pre-injection strategy to prevent oesophageal stricture after circumferential endoscopic submucosal dissection.

Project description: Not available

| S-EPMC11503086 | biostudies-literature